Double‐blind , placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression-Reference-Cited by-同舟云学术

Double‐blind , placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression

Author:

Kato Tadafumi¹²^ORCID,Ishigooka Jun³,Miyajima Mari⁴,Watabe Kei⁴,Fujimori Tomohiro⁴⁵,Masuda Takahiro⁴^ORCID,Higuchi Teruhiko⁶⁷,Vieta Eduard⁸

Affiliation:

1. Department of Psychiatry Juntendo University Tokyo Japan

2. Laboratory for Molecular Dynamics of Mental Disorders RIKEN Center for Brain Science Wako Japan

3. Institute of CNS Pharmacology Tokyo Japan

4. Sumitomo Dainippon Pharma Co., Ltd. Tokyo Japan

5. Sunovion Pharmaceuticals Inc. Marlborough USA

6. Japan Depression Center Tokyo Japan

7. The National Center of Neurology and Psychiatry Kodaira Japan

8. Bipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neurosciences University of Barcelona, IDIBAPS, CIBERSAM Barcelona Spain

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,General Medicine,General Neuroscience

Link

Reference53 articles.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献